Introduction
Bioenergetic failure due to mitochondrial dysfunction has been implicated as an important pathophysiological mechanism underlying poor outcome in critical illness.
Objectives
We examined the longitudinal changes of ATP, N02ā nd N03¯in patients with severe sepsis (SS) or traumarelated systemic inflammatory response syndrome (SIRS) compared to healthy-controls (H) and their relations to intracellular heat shock proteins (HSP)-72 and -90α, metabolism and outcome.
Methods
Seventy-eight adults (SS/22; non-infectious SIRS /23; healthy (H)/33) and sixty-two children (SS/15; noninfectious SIRS /20; healthy (H)/27) were studied. Blood samples obtained on days 1, 3 and 5. Energy expenditure (EE) of patients was measured with the Gas Module E-COVX. HSPs expressions in monocytes (m) or neutrophils (n) were determined using flow cytometry. ATP concentrations were measured by the luciferase luminescent assay. N02¯and N03¯determination was performed using the Sievers Nitric Oxide Analyzer.
Results
In both, adults and children, mitochondrial bioenergetics showed different longitudinal trends for survivors and non-survivors. The nitrite/nitrate ratio increased longitudinally in critical illness (p < 0.05). Among adult survivors, N03¯(26422 ± 19368 vs. 13807 ± 3740nM, p < 0.04) and ATP concentrations (503 ± 645 vs. 185 ± 192nM) decreased from day 1 to 3, and lactate from days 1 to 3 to 5 (15 ± 11 vs. 10 ± 4 vs. 8 ± 5mMol/L, p < 0.001). Survivors had higher ATP, N03¯(p < 0.04), N02¯(p < 0.04), V02 (p < 0.0001), VC02 (p < 0.0001), EE (p < 0.04) on day 1, N02¯(p < 0.05) on day 3, and lower lactate levels on days 1 and 5 (p < 0.03), compared to non-survivors. Nonsurvived children had lower SID (28 ± 5 vs. 34 ± 4, p < 0.03) and mHSP72 (16 ± 13 vs. 23 ± 15 MFI, p < 0.05) on days 1, 5.
Conclusions
Our data implicate bioenergetic failure and a drop in NO synthesis in white blood cells as possible pathophysiological mechanisms contributing to mortality. Our data suggest that in critically ill patients NO metabolism is linked to HSP72 and has a protective impact on mitochondrial function.
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